Aripiprazole Injection bulk supplier for pharma manufacturers

Aripiprazole Injection Suppliers & Bulk Manufacturers

Available Forms: Intramuscular (IM) Injection

Available Strengths: Short-acting: 9.75 mg/1.3 mL; Long-acting: 300 mg, 400 mg (monthly)

Reference Brands: Abilify(EU & US)

Aripiprazole, marketed as Abilify, is a widely used antipsychotic available in oral and injectable forms across the US and EU. Offered in strengths from 2 mg to 400 mg, it supports schizophrenia and bipolar treatment. Pharma buyers source aripiprazole in bulk from certified suppliers for mental health distribution channels.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Aripiprazole Injection? List it or send an offer →

Product Description:

Aripiprazole is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, depression adjunct, and autism-related irritability. It is available in multiple dosage forms including oral tablets (2–30 mg), orally disintegrating tablets, oral solution (1 mg/mL), and IM injections (short and long-acting). Brands like Abilify and Abilify Maintena are widely marketed in the US and EU. Long-acting injectable forms (300 mg, 400 mg) are particularly preferred in maintenance therapy. Pharmaceutical distributors and bulk buyers source aripiprazole in various formulations for hospital use, psychiatric facilities, and retail pharmacy networks. Reliable GMP-compliant manufacturers offer consistent global B2B supply.

Aripiprazole Injection — third party manufacturing & bulk supply

Aripiprazole Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Aripiprazole Injection is supplied as Intramuscular (IM) Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Aripiprazole Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Aripiprazole Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Aripiprazole is used to treat psychiatric and neurological conditions such as schizophrenia, bipolar disorder, major depressive disorder (as an adjunct therapy), irritability associated with autism, and Tourette syndrome. It helps stabilize mood, behavior, and thought processes.

Aripiprazole is made from the active pharmaceutical ingredient aripiprazole, an atypical antipsychotic compound that acts on dopamine and serotonin receptors in the brain.

Aripiprazole is marketed under the trade name Abilify, along with other brand names depending on formulation and region.

Aripiprazole is manufactured and marketed by multiple pharmaceutical companies worldwide. The original brand Abilify was developed and marketed by Otsuka Pharmaceutical in collaboration with Bristol Myers Squibb.

The complete generic name is aripiprazole.

A well-known brand name of aripiprazole is Abilify.

Aripiprazole is manufactured in FDA-, EMA-, and MHRA-approved facilities across the USA, EU, UK, and other regulated markets, depending on the manufacturer and dosage form.